CD81 通过阻断 CD274/PD-L1 的选择性自噬降解驱动放射抵抗性胶质母细胞瘤的免疫逃逸
CD81 drives immune evasion in radioresistant glioblastoma by blocking selective autophagic degradation of CD274/PD-L1.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:BMSC-exosomes miR-25-3p Regulates the p53 Signaling Pathway Through PTEN to Inhibit Cell Apoptosis and Ameliorate Liver Ischemia‒reperfusion Injury.
BMSC-exosomes miR-25-3p Regulates the p53 Signaling Pathway Through PTEN to Inhibit Cell Apoptosis and Ameliorate Liver Ischemia‒reperfusion Injury.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
我们揭示了 BMSC-Exos 和 miR-25 在 HIRI 中的作用及潜在机制,有助于 HIRI 的预防和治疗。
肝缺血再灌注损伤(HIRI)是肝脏手术期间的一种病理现象;骨髓间充质干细胞外泌体(BMSC-Exos)可调节细胞凋亡并减轻缺血再灌注损伤。本研究旨在探讨 BMSC-Exos 及其富集的 miR-25b-3p 在 HIRI 中的作用,并阐明相关机制。方法与结果:构建 HIRI 小鼠模型,并经尾静脉预先注射 BMSC-Exos、agomir-miR-25、agomir-miR-NC 或 PBS。与 HIRI 小鼠相比,预先注射 BMSC-Exos 的 HIRI 小鼠丙氨酸氨基转移酶(ALT)和天冬氨酸氨基转移酶(AST)水平显著降低,肝坏死减轻(P < 0.05)。肝脏整体转录组定量分析显示,预先注射 BMSC-Exos 的 HIRI 小鼠细胞分裂、造血或淋巴器官发育及代谢过程增加。BMSC-Exos 的 miRNA 测序显示,与缺血/再灌注损伤相关的 miR-25 在外泌体中富集。与 HIRI + NC 小鼠相比,HIRI + miR-25b-3p 小鼠 miR-25b-3p 表达显著增加,ALT/AST 水平和凋亡相关蛋白表达降低(P < 0.05),肝坏死也有所减轻。缺氧诱导后,转染 miR-25b-3p 的 AML-12 细胞增殖显著高于 mimic NC 组(P < 0.01),细胞凋亡率显著低于 NC 组(P < 0.01)。研究确定 PTEN 是 miR-25b-3p 的靶基因;转染 miR-25b-3p 的 AML-12 细胞中 PTEN 表达显著降低(P < 0.05)。与 HIRI + NC 小鼠相比,HIRI + agomir-miR-25 小鼠 PTEN 表达降低,p53 和 cleaved caspase 3 水平也下降。
本研究揭示了 BMSC-Exos 和 miR-25 在 HIRI 中的作用及其潜在机制,为预防和治疗 HIRI 提供了参考。
Hepatic ischemia reperfusion injury (HIRI) is a pathological phenomenon during liver surgery, and bone marrow-mesenchymal stem cell (BMSC) exosomes (BMSC-Exos) regulate cell apoptosis and reduce ischemia reperfusion injury. We aimed to investigate the roles of BMSC-Exos and miR-25b-3p (enriched in BMSC-Exos) in HIRI and elucidate the underlying mechanisms. APPROACHES AND RESULTS: An HIRI mouse model was constructed and preinjected with BMSC-Exos, agomir-miR-25, agomir-miR-NC, or PBS via the tail vein. Compared with mice with HIRI, mice with HIRI preinjected with BMSC-Exos had significantly decreased alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels and alleviated liver necrosis (P < 0.05). Quantitative hepatic transcriptomics showed that mice with HIRI preinjected with BMSC-Exos exhibited increased cell division, hematopoietic or lymphoid organ development and metabolic processes. miRNA sequencing of BMSC-Exos revealed that miR-25, which is related to I/R injury, was enriched in the exosomes. Compared with HIRI + NC mice, HIRI + miR-25b-3p mice had significantly increased miR-25b-3p expression, decreased ALT/AST levels and apoptosis-related protein expression (P < 0.05), and alleviated liver necrosis. The proliferation of AML-12 cells transfected with miR-25b-3p was significantly higher than that in the mimic NC group (P < 0.01) after hypoxia induction, and the apoptosis rate of cells was significantly lower than that in the NC group (P < 0.01). PTEN was identified as a miR-25b-3p target gene. PTEN expression was significantly diminished in miR-25b-3p-transfected AML12 cells (P < 0.05). HIRI + agomir-miR-25 mice displayed reduced PTEN expression and decreased p53 and cleaved caspase 3 levels compared to HIRI + NC mice.
We revealed the roles and underlying mechanisms of BMSC-Exos and miR-25 in HIRI, contributing to the prevention and treatment of HIRI.
MEMBER ACCOUNT
登录成功会直接打开下一页。